Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11)
Published October 8, 2025 · Recall initiated: September 15, 2025
Summary
FDA records drug Class II recall D-0675-2025, published October 8, 2025 and initiated September 15, 2025. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 360 cartons; Lot: Lot #: 1024078, Exp. Date 08/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if CARBAMAZEPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CARBAMAZEPINE
- Manufacturer
- Amerisource Health Services LLC
- Distributor
- Nationwide in the USA.
- Lot
- Lot #: 1024078, Exp. Date 08/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottlesAugust 26, 2026
- FDACarbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro PharmaceuticalAugust 26, 2026
- FDAEntecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,October 8, 2025
- FDABrimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile,October 8, 2025
- FDACarbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: TorrentJanuary 19, 2022
- FDACarbamazepine 200mg Tablets, USP, 200 mg, 100 Count Unit Dose Cartons, Rx only, Manufactured by: TorrentSeptember 29, 2021
Questions about this recall
Was Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11) recalled?
Yes. FDA published recall D-0675-2025 on October 8, 2025. Reported hazard: Failed Dissolution Specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CARBAMAZEPINE.